[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([CH:8]=[C:9]2[S:13][C:12](=[O:14])[N:11]([CH2:15][CH2:16][CH2:17][CH2:18][S:19][C:20]3[N:25]4[CH:26]=[CH:27][N:28]=[C:24]4[CH:23]=[CH:22][CH:21]=3)[C:10]2=[O:29])[CH2:4][CH2:3]1.[ClH:30]>CO>[ClH:30].[ClH:30].[ClH:30].[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([CH:8]=[C:9]2[S:13][C:12](=[O:14])[N:11]([CH2:15][CH2:16][CH2:17][CH2:18][S:19][C:20]3[N:25]4[CH:26]=[CH:27][N:28]=[C:24]4[CH:23]=[CH:22][CH:21]=3)[C:10]2=[O:29])[CH2:4][CH2:3]1To a solution of 330 mg (0.76 mmol) of 5-(1-methylpiperazin-4-yl)methylene-3-[4-(imidazo[1,2-a]pyridin-5-ylthio)butyl]thiazolidine-2,4-dione in 10 ml of methanol, concentrated hydrochloric acid was added. After the solvent was distilled off, the residue was washed with diethyl ether to yield 360 mg (82.0%, white crystal) of the desired product.